Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia. [electronic resource]
- Current opinion in oncology Jul 1998
- 291-6 p. digital
Publication Type: Journal Article; Review
1040-8746
10.1097/00001622-199807000-00003 doi
Colony-Stimulating Factors--economics Cost-Benefit Analysis Drug-Related Side Effects and Adverse Reactions Fever--drug therapy Granulocyte Colony-Stimulating Factor--economics Granulocyte-Macrophage Colony-Stimulating Factor--economics Humans Neutropenia--complications